Over the last 7 days, the Biotech industry has dropped 10%, driven by Akeso declining 33%. On the other hand CARsgen Therapeutics Holdings is actually up 9.8%. The industry has fallen 37% in the last year. As for the next few years, earnings are expected to grow by 37% per annum.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Thu, 30 May 2024 | HK$327.6b | HK$49.8b | -HK$19,496,944,310.65 | 10.7x | -16.8x | 6.6x |
Sat, 27 Apr 2024 | HK$356.8b | HK$49.5b | -HK$19,466,746,223.62 | 11.9x | -18.3x | 7.2x |
Mon, 25 Mar 2024 | HK$345.6b | HK$49.7b | -HK$19,699,938,439.12 | 14.1x | -17.5x | 7x |
Wed, 21 Feb 2024 | HK$334.9b | HK$46.8b | -HK$20,169,434,820.59 | 16.7x | -16.6x | 7.2x |
Fri, 19 Jan 2024 | HK$356.0b | HK$46.8b | -HK$20,179,533,390.00 | 17.3x | -17.6x | 7.6x |
Sun, 17 Dec 2023 | HK$406.1b | HK$47.1b | -HK$20,339,000,495.00 | 17.9x | -20x | 8.6x |
Tue, 14 Nov 2023 | HK$409.2b | HK$45.2b | -HK$18,917,442,048.00 | 13.6x | -21.6x | 9.1x |
Thu, 12 Oct 2023 | HK$392.6b | HK$44.9b | -HK$19,102,915,645.00 | 13.9x | -20.6x | 8.7x |
Sat, 09 Sep 2023 | HK$402.2b | HK$44.8b | -HK$18,854,481,037.00 | 15.4x | -21.3x | 9x |
Mon, 07 Aug 2023 | HK$398.2b | HK$35.6b | -HK$23,393,254,800.00 | 22.3x | -17x | 11.2x |
Wed, 05 Jul 2023 | HK$412.9b | HK$35.4b | -HK$23,279,014,142.00 | 25.5x | -17.7x | 11.7x |
Fri, 02 Jun 2023 | HK$408.8b | HK$35.8b | -HK$23,623,817,169.00 | 27.5x | -17.3x | 11.4x |
Sun, 30 Apr 2023 | HK$444.9b | HK$37.1b | -HK$23,353,957,554.00 | 17.8x | -19.1x | 12x |
Tue, 28 Mar 2023 | HK$434.1b | HK$35.1b | -HK$35,011,853,187.00 | 23.5x | -12.4x | 12.4x |
Thu, 23 Feb 2023 | HK$415.1b | HK$34.5b | -HK$34,789,181,444.00 | 33.3x | -11.9x | 12x |
Sat, 21 Jan 2023 | HK$452.1b | HK$34.9b | -HK$35,261,292,869.00 | 29.8x | -12.8x | 13x |
Mon, 19 Dec 2022 | HK$394.6b | HK$33.6b | -HK$33,868,975,451.00 | 24.3x | -11.7x | 11.8x |
Wed, 16 Nov 2022 | HK$379.5b | HK$33.4b | -HK$33,666,828,900.00 | 17.8x | -11.3x | 11.4x |
Fri, 14 Oct 2022 | HK$277.4b | HK$33.8b | -HK$32,282,437,029.00 | 15.7x | -8.6x | 8.2x |
Sun, 11 Sep 2022 | HK$356.2b | HK$34.5b | -HK$33,767,111,427.00 | 16.9x | -10.5x | 10.3x |
Tue, 09 Aug 2022 | HK$338.4b | HK$32.8b | -HK$46,282,522,083.00 | 12x | -7.3x | 10.3x |
Thu, 07 Jul 2022 | HK$382.6b | HK$33.0b | -HK$46,512,140,844.00 | 15.2x | -8.2x | 11.6x |
Sat, 04 Jun 2022 | HK$326.3b | HK$34.2b | -HK$46,188,313,755.00 | 13.2x | -7.1x | 9.5x |
Mon, 02 May 2022 | HK$337.9b | HK$35.5b | -HK$44,796,407,626.00 | 13.3x | -7.5x | 9.5x |
Wed, 30 Mar 2022 | HK$330.1b | HK$36.1b | -HK$38,867,501,653.00 | 15.1x | -8.5x | 9.1x |
Fri, 25 Feb 2022 | HK$322.1b | HK$33.0b | -HK$31,387,875,444.00 | 12.7x | -10.3x | 9.7x |
Sun, 23 Jan 2022 | HK$361.7b | HK$31.2b | -HK$31,915,022,406.00 | 13.1x | -11.3x | 11.6x |
Tue, 21 Dec 2021 | HK$410.7b | HK$31.1b | -HK$31,807,684,351.00 | 13.1x | -12.9x | 13.2x |
Thu, 18 Nov 2021 | HK$518.3b | HK$31.0b | -HK$31,631,124,621.00 | 14.3x | -16.4x | 16.7x |
Sat, 16 Oct 2021 | HK$497.3b | HK$30.5b | -HK$31,542,297,012.00 | 14.5x | -15.8x | 16.3x |
Mon, 13 Sep 2021 | HK$515.5b | HK$30.4b | -HK$31,412,511,864.39 | 17.2x | -16.4x | 17x |
Wed, 11 Aug 2021 | HK$566.0b | HK$30.2b | -HK$32,058,827,347.35 | 14.9x | -17.7x | 18.7x |
Sun, 06 Jun 2021 | HK$629.6b | HK$27.8b | -HK$26,637,487,691.09 | 21.6x | -23.6x | 22.7x |
-23.6x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | -2.07% | |
Healthcare | -5.87% | |
Biotech | -10.47% | |
Biotech | -10.47% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2171 CARsgen Therapeutics Holdings | HK$7.06 | 9.8% +HK$362.7m | -32.0% | PB2.1x | |
6185 CanSino Biologics | HK$22.15 | 3.7% +HK$197.6m | -23.9% | PS13.7x | |
1875 TOT BIOPHARM International | HK$2.10 | 8.2% +HK$123.6m | -14.3% | PS1.9x | |
2142 HBM Holdings | HK$1.44 | 2.9% +HK$29.3m | -15.3% | PE5.9x | |
1541 ImmuneOnco Biopharmaceuticals (Shanghai) | HK$14.48 | 0.1% +HK$7.5m | n/a | PS641.9x |